Panel discussion: how I treat metastatic HER2-positive breast cancer

HER2 breast cancer

Gain an understanding of how oncologists are treating metastatic HER2-positive breast cancer in Oncology Central’s latest panel discussion, featuring experts from international institutions including Hans-Christian Kolberg (Marienhospital Bottrop, Germany), Franklin Castillero (National Oncology Institute of Panama) and Max Mano (Hospital Sírio-Libanês, São Paulo, Brazil). The panelists discuss the past, present and future of the treatment landscape for HER2-positive breast cancer, and detail the treatments and sequencing used in their own practice. Kolberg, Castillero and Mano also present their own case studies and discuss how they would approach each other’s cases. Read the full panel discussion below and keep up to...

To view this content, please register now for access

It's completely free